Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.5 updated from v3.6.4, signaling a software update to the page. This change does not appear to modify the study content or displayed information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a new internal revision. This appears to be maintenance-only and does not reflect changes to the study information or user-visible content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision label has been updated to v3.6.3, indicating a new version of the page. This reflects a small administrative update to the page without changing the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.SummaryDifference0.0%

- Check65 days agoChange DetectedThe study page gains new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that enrollment is closed, while the Intervention/Treatment header formatting is updated and the page revision is bumped to v3.6.0.SummaryDifference0.4%

- Check72 days agoChange DetectedA new revision tag (v3.5.5) was added and the previous tag (v3.5.4) removed, signaling a recent deployment update of the page.SummaryDifference0.0%

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.